IIR 16-262
Association of Complementary and Integrative Health (CHI) Interventions with Opioid Use and Related Risks Among Veterans With Musculoskeletal Disorders (MSD) and PTSD
Joseph Lucien Goulet, PhD MS VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, CT Qing Zeng PhD Washington DC VA Medical Center, Washington, DC Washington, DC Funding Period: May 2018 - April 2022 |
BACKGROUND/RATIONALE:
Opioids misuse, abuse, addiction, and overdose have become serious public health worldwide. They are also a leading cause of death in the USA. Complementary and integrative health (CIH) interventions may help prevent or reduce opioid related harms. However, an April 2016 QUERI ESP report stated that "the evidence base regarding the effectiveness of select CIH interventions for reducing opioid use is extremely limited." Strategies to identify CIH use and its effects are needed. The impact of CIH on opioid use, co-prescriptions, pain and related outcomes in VA is poorly understood. Because Veterans with PTSD are at higher risk for opioid related harms, and because of the potential mutual reinforcement of PTSD and pain symptoms, CIH may have substantial impact on decreasing rates of opioid initiation and harms. We will examine CIH use and non-use among Veterans with musculoskeletal disorders (MSD) and compare opioid and pain outcomes by PTSD status. OBJECTIVE(S): Our aims are to assess the impact of CIH on opioid initiation among Veterans with MSD, estimate whether the effect varies by Veterans demographic and clinical characteristics, with particular attention to Veterans with PTSD status, and to examine potential harms of CIH use. METHODS: We will use algorithms from the Musculoskeletal Disorders cohort study (CRE12-012) to identify Veterans with MSD, and identify CIH use via structured data (e.g. procedure and ICD codes) and informatics tools on unstructured data (e.g. clinical notes). We will examine acupuncture, massage, meditation/mindfulness and yoga as they are currently or likely to be integrated into routine VA care. Using structured data only, we identified 7,621 CIH users among MSD cohort entrants in FY11-FY13 (n= 309,277); of which, 21% had a PTSD diagnosis. Opioid and other medications will be identified from pharmacy data. FINDINGS/RESULTS: None to date IMPACT: None to date External Links for this ProjectNIH ReporterGrant Number: I01HX002308-01A1Link: https://reporter.nih.gov/project-details/9393072 Dimensions for VADimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.Learn more about Dimensions for VA. VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address. Search Dimensions for this project PUBLICATIONS:Journal Articles
DRA:
Mental, Cognitive and Behavioral Disorders, Musculoskeletal Disorders
DRE: TRL - Applied/Translational, Epidemiology, Treatment - Observational Keywords: Pain, Substance Use and Abuse, Surveillance, Technology Development, Utilization MeSH Terms: none |